Attend the FierceBiotech 3rd Drug Development Forum!
The leading executive-level forum for biotech strategy & networking | Oct 1-3 | Boston
Benchling raised $14.5 million in series B funding to build out its staff and develop its cloud-based data management and collaborative R&D platforms.
Admescope has acquired Swedish CRO MetaSafe, which focuses on metabolic research and drug biotransformation. Financial terms were not disclosed.
Implementation guidelines to support GxP in the cloud
Icon signed an agreement with AG Mednet to use its electronic endpoint adjudication system to manage workflow and ensure data quality.
LabCorp acquired postmarket services provider Sciformix and plans to integrate it with Covance. The terms of the deal were not disclosed.
This informative eBook explores technology currently being used to improve clinical trial efficiency, while also offering a peek into the emerging technologies…
WuXi AppTec partnered up with Insilico Medicine through a venture capital investment in its AI-driven drug and biomarker discovery platforms.
New Chinese data management and transfer rules passed this year could be tripping up global pharma collaborations and research.
SoftBank is considering a $150 million investment in siteless trial runner Science 37, the latest in a string of biotech deals, according to reports.
More details on Amazon’s secret skunk-works research division have been revealed, including work in cancer research and EHRs, in reports from CNBC.
Syngene partnered with Zumutor to screen antigens against Zumutor’s human antibody libraries, to discover antibody clones for additional development.
PPD and NeoGenomics plan to integrate their pathology and molecular testing services, with a focus on clinical trials in oncology.